Actinium Pharmaceuticals (ATNM)
NYSE MKT:ATNM

Actinium Pharmaceuticals (ATNM) Stock Price & Analysis

1,840 Followers

ATNM Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$5.87 - $15.12
Previous Close$5.92
Volume210.67K
Average Volume (3M)161.45K
Market Cap
$165.53M
Enterprise Value$77.70M
Total Cash (Recent Filing)$91.28M
Total Debt (Recent Filing)$9.15M
Price to Earnings (P/E)-3.3
Beta0.68
Mar 15, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.80
Shares Outstanding26,997,587
10 Day Avg. Volume164,141
30 Day Avg. Volume161,452
Standard Deviation0.24
R-Squared0.00776
Alpha-0.00019
Financial Highlights & Ratios
Price to Book (P/B)3.01
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.73K
Enterprise Value/Gross Profit75.44
Enterprise Value/Ebitda-3.26
Forecast
Price Target Upside419.83% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4


Financials

Annual

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.

---

ATNM FAQ

What was Actinium Pharmaceuticals’s price range in the past 12 months?
Actinium Pharmaceuticals lowest stock price was $5.87 and its highest was $15.12 in the past 12 months.
    What is Actinium Pharmaceuticals’s market cap?
    Currently, no data Available
    When is Actinium Pharmaceuticals’s upcoming earnings report date?
    Actinium Pharmaceuticals’s upcoming earnings report date is Mar 15, 2024 which is in 164 days.
      How were Actinium Pharmaceuticals’s earnings last quarter?
      Currently, no data Available
      Is Actinium Pharmaceuticals overvalued?
      According to Wall Street analysts Actinium Pharmaceuticals’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does Actinium Pharmaceuticals pay dividends?
        Actinium Pharmaceuticals does not currently pay dividends.
        What is Actinium Pharmaceuticals’s EPS estimate?
        Actinium Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Actinium Pharmaceuticals have?
        Actinium Pharmaceuticals has 26,997,587 shares outstanding.
          What happened to Actinium Pharmaceuticals’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Actinium Pharmaceuticals?
          Among the largest hedge funds holding Actinium Pharmaceuticals’s share is Royce & Associates LLC. It holds Actinium Pharmaceuticals’s shares valued at 371K.

            ---

            Actinium Pharmaceuticals Stock Smart Score

            The Actinium Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
            Learn more about TipRanks Smart Score

            Company Description

            Actinium Pharmaceuticals

            Actinium Pharmaceuticals, Inc. is a clinical-stage, Biopharmaceutical Company focused on developing and potentially commercializing therapies to cell therapies. The firm's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells. Its product pipeline includes Iomab-B, Actimab-A, and Actimab-M. The company was founded in 1993 and is headquartered in New York, NY.

            ---

            Top 5 ETFs holding ATNM

            Name
            Market Value
            Smart Score
            Vanguard Total Stock Market ETF
            $4.77M
            8
            Vanguard Russell 3000 ETF
            $9.85K
            8
            Up to five ETFs with an Outperform Smart Score that hold ATNM. The ETFs are listed according to market value of ATNM within the ETF

            Forecast EPS vs Actual EPS

            Currently, no data available
            Please return soon. This page is being updated.

            Similar Stocks
            Company
            Price & Change
            Follow
            Atossa Therapeutics
            Brainstorm Cell Therapeutics
            Bio-Path Holdings
            Cellectar Biosciences

            Popular Stocks

            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis